» Articles » PMID: 35947248

In Silico Study of Tacrine and Acetylcholine Binding Profile with Human Acetylcholinesterase: Docking and Electronic Structure

Overview
Journal J Mol Model
Publisher Springer
Specialty Molecular Biology
Date 2022 Aug 10
PMID 35947248
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer disease (AD) is a neurodegenerative process, one of the most common and incident dementia in the population over 60 years. AD manifests the presence of complex biochemical processes involved in neuronal degeneration, such as the formation of senile plaques containing amyloid-β peptides, the development of intracellular neurofibrillary tangles, and the suppression of the acetylcholine neurotransmitter. In this way, we performed a set of theoretical tests of tacrine ligand and acetylcholine neurotransmitter against the human acetylcholinesterase enzyme. Molecular docking was used to understand the most important interactions of these molecules with the enzyme. Computational chemistry calculation was carried out using MP2, DFT, and semi-empirical methods, starting from molecular docking structures. We have also performed studies regarding the non-covalent interactions, electron localization function, molecular electrostatic potential and explicit water molecule influence. For Trp86 residue, we show two main interactions in accordance to the results of the literature for TcAChE. First, intermolecular interactions of the cation-π and sigma-π type were found. Second, close stacking interactions were stablished between THA+ and Trp86 residue on one side and with Tyr337 residue on the other side.

Citing Articles

Docking heparan sulfate-based ligands as a promising inhibitor for SARS-CoV-2.

Benicio L, Nascimento E, Martins J J Mol Model. 2024; 31(1):19.

PMID: 39666205 DOI: 10.1007/s00894-024-06236-0.


In Silico Molecular Modeling of Four New Afatinib Derived Molecules Targeting the Inhibition of the Mutated Form of BCR-ABL T315I.

Rocha K, Nascimento E, de Jesus R, Martins J Molecules. 2024; 29(17).

PMID: 39275102 PMC: 11397288. DOI: 10.3390/molecules29174254.


A Mouse Model of Sporadic Alzheimer's Disease with Elements of Major Depression.

Bobkova N, Chuvakova L, Kovalev V, Zhdanova D, Chaplygina A, Rezvykh A Mol Neurobiol. 2024; 62(2):1337-1358.

PMID: 38980563 DOI: 10.1007/s12035-024-04346-7.


Comparative analysis of the reactivity of anthocyanidins, leucoanthocyanidins, and flavonols using a quantum chemistry approach.

de Souza Farias S, Costa K, Martins J J Mol Model. 2023; 29(4):93.

PMID: 36905478 PMC: 10006565. DOI: 10.1007/s00894-023-05468-w.

References
1.
Zhang H, Wu J, Zhu J . The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Dev Immunol. 2010; 2010:186813. PMC: 2896842. DOI: 10.1155/2010/186813. View

2.
Ohno-Shosaku T, Matsui M, Fukudome Y, Shosaku J, Tsubokawa H, Taketo M . Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus. Eur J Neurosci. 2003; 18(1):109-16. DOI: 10.1046/j.1460-9568.2003.02732.x. View

3.
Suzuki E, Momiyama T . M1 muscarinic acetylcholine receptor-mediated inhibition of GABA release from striatal medium spiny neurons onto cholinergic interneurons. Eur J Neurosci. 2020; 53(3):796-813. DOI: 10.1111/ejn.15074. View

4.
Baxter M, Crimins J . Acetylcholine Receptor Stimulation for Cognitive Enhancement: Better the Devil You Know?. Neuron. 2018; 98(6):1064-1066. DOI: 10.1016/j.neuron.2018.06.018. View

5.
Rosini M, Simoni E, Bartolini M, Cavalli A, Ceccarini L, Pascu N . Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush. J Med Chem. 2008; 51(15):4381-4. DOI: 10.1021/jm800577j. View